Delhi AIIMS chief Dr. Randeep Guleria said that Covaxin's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month.
from Zee News :India National https://ift.tt/3xFV2wH
Mandate 2024 | Pollpourri from India Today | Nation https://ift.tt/3HT8Vk2
0 Comments